Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
Public ClinicalTrials.gov record NCT07220915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients With Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment With B-cell Depletion Therapy ("PROTECT")
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therapy
Study identification
- NCT ID
- NCT07220915
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 360 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2026 (Actual)
- Primary completion
- Dec 2029 (Estimated)
- Completion
- Dec 2029 (Estimated)
- Last update posted
- Sep 29, 2026
2026 – 2029
United States locations
- U.S. sites
- 6
- U.S. states
- 2
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Phoenix | Glendale | Arizona | 85306 | Active, not recruiting |
| AARA Clinical Research - Arizona Arthritis and Rheumatology Associates - Mesa | Mesa | Arizona | 85210 | Recruiting |
| Perseverance Research Center, Phoenix Neurological Associates | Scottsdale | Arizona | 85253 | Recruiting |
| AARA Clinical Research - Arizona Arthritis and Rheumatology Associates - Tucson | Tucson | Arizona | 85704 | Active, not recruiting |
| AARA Clinical Research - Lone Star Arthritis & Rheumatology Associates - Fort Worth | Fort Worth | Texas | 76109 | Active, not recruiting |
| AARA Clinical Research - Lone Star Arthritis & Rheumatology Associates - Irving 6750 N. MacArthur Blvd, Suite 304 | Irving | Texas | 75039 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07220915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07220915 live on ClinicalTrials.gov.